• Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

    Source: Buzz FX / 25 Nov 2024 03:26:10   America/Chicago


    Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Consensus Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat November 25, 2024 Share Link copied to clipboard. Shares of Terns Pharmaceuticals, Inc.
    Read more...
Share on,